Study About Preventive Treatment of Folliculitis Induced by Epidermal Growth Factor Receptor Inhibitors

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Metastatic Colorectal CancerNon-Small-Cell Lung Carcinoma
Interventions
DRUG

Diprosone

"* Start of treatment: as soon as the EGF-R inhibitors treatment begins~* Application: On the body area susceptible to be affected by folliculitis, once a day, in the evening~* Dosage: Quantity corresponded to around 2 tubes of 30 grams a week on the face, the chest and upper side of the back. There is no maximum dosage.~* Period of treatment: 8 weeks"

Trial Locations (3)

59020

Centre Oscar Lambret, Lille

59035

Centre Hospitalier Regional, Lille

Centre Hospitalier Régional, Lille

All Listed Sponsors
collaborator

Roche Pharma AG

INDUSTRY

lead

Centre Oscar Lambret

OTHER

NCT00910676 - Study About Preventive Treatment of Folliculitis Induced by Epidermal Growth Factor Receptor Inhibitors | Biotech Hunter | Biotech Hunter